Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells

Savvas E. Papanicolaou, Roger J. Phipps, David P Fyhrie, Damian C Genetos

Research output: Contribution to journalArticle

43 Citations (Scopus)

Abstract

The anabolic effect of dynamic mechanical loading on skeletal architecture has been repeatedly demonstrated, but the cellular and molecular events occurring between load and ultimate bone formation remain obscure. The discovery of sclerostin, an antagonist of Wnt/Lrp5 signaling, and the sclerosing bone dysplasias that result from its mutation suggest its pivotal role in modulating bone formation. We examined expression of Sost mRNA across a variety of clonal cell lines spanning the osteogenic phenotype from immature osteoblast to mature osteocyte. No sclerostin expression was detected in immature MC3T3-E1 osteoblasts and, surprisingly, mature MLO-Y4 osteocytes, whereas immature MLO-A5 osteocytic cells expressed very low levels of Sost. Highest expression was observed in mature UMR 106.01 osteoblasts. We examined the influence of bone morphogenetic proteins on Sost expression. Treatment with BMP-2, -4 or -6 was without effect on Sost in mature MLO-Y4 osteocytes but elicited a robust increase in Sost expression in immature MLO-A5 osteocytes. Oscillatory fluid flow applied to mature UMR 106.01 osteoblasts transiently decreased expression of sclerostin at both the mRNA and protein level. Overall, our results indicate that BMP treatment and in vitro mechanical loading demonstrate opposite effects upon sclerostin expression.

Original languageEnglish (US)
Pages (from-to)389-399
Number of pages11
JournalBiorheology
Volume46
Issue number5
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Osteocytes
Bone Morphogenetic Proteins
Osteoblasts
Osteogenesis
Developmental Bone Disease
Anabolic Agents
Messenger RNA
Phenotype
Cell Line
Mutation
Proteins

Keywords

  • BMP
  • Fluid flow
  • Osteoblast
  • Osteocyte
  • Shear stress
  • Sost

ASJC Scopus subject areas

  • Physiology (medical)
  • Physiology

Cite this

Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells. / Papanicolaou, Savvas E.; Phipps, Roger J.; Fyhrie, David P; Genetos, Damian C.

In: Biorheology, Vol. 46, No. 5, 2009, p. 389-399.

Research output: Contribution to journalArticle

@article{6ccc9c03710c4f3588fd56e371ad6aa7,
title = "Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells",
abstract = "The anabolic effect of dynamic mechanical loading on skeletal architecture has been repeatedly demonstrated, but the cellular and molecular events occurring between load and ultimate bone formation remain obscure. The discovery of sclerostin, an antagonist of Wnt/Lrp5 signaling, and the sclerosing bone dysplasias that result from its mutation suggest its pivotal role in modulating bone formation. We examined expression of Sost mRNA across a variety of clonal cell lines spanning the osteogenic phenotype from immature osteoblast to mature osteocyte. No sclerostin expression was detected in immature MC3T3-E1 osteoblasts and, surprisingly, mature MLO-Y4 osteocytes, whereas immature MLO-A5 osteocytic cells expressed very low levels of Sost. Highest expression was observed in mature UMR 106.01 osteoblasts. We examined the influence of bone morphogenetic proteins on Sost expression. Treatment with BMP-2, -4 or -6 was without effect on Sost in mature MLO-Y4 osteocytes but elicited a robust increase in Sost expression in immature MLO-A5 osteocytes. Oscillatory fluid flow applied to mature UMR 106.01 osteoblasts transiently decreased expression of sclerostin at both the mRNA and protein level. Overall, our results indicate that BMP treatment and in vitro mechanical loading demonstrate opposite effects upon sclerostin expression.",
keywords = "BMP, Fluid flow, Osteoblast, Osteocyte, Shear stress, Sost",
author = "Papanicolaou, {Savvas E.} and Phipps, {Roger J.} and Fyhrie, {David P} and Genetos, {Damian C}",
year = "2009",
doi = "10.3233/BIR-2009-0550",
language = "English (US)",
volume = "46",
pages = "389--399",
journal = "Biorheology",
issn = "0006-355X",
publisher = "IOS Press",
number = "5",

}

TY - JOUR

T1 - Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells

AU - Papanicolaou, Savvas E.

AU - Phipps, Roger J.

AU - Fyhrie, David P

AU - Genetos, Damian C

PY - 2009

Y1 - 2009

N2 - The anabolic effect of dynamic mechanical loading on skeletal architecture has been repeatedly demonstrated, but the cellular and molecular events occurring between load and ultimate bone formation remain obscure. The discovery of sclerostin, an antagonist of Wnt/Lrp5 signaling, and the sclerosing bone dysplasias that result from its mutation suggest its pivotal role in modulating bone formation. We examined expression of Sost mRNA across a variety of clonal cell lines spanning the osteogenic phenotype from immature osteoblast to mature osteocyte. No sclerostin expression was detected in immature MC3T3-E1 osteoblasts and, surprisingly, mature MLO-Y4 osteocytes, whereas immature MLO-A5 osteocytic cells expressed very low levels of Sost. Highest expression was observed in mature UMR 106.01 osteoblasts. We examined the influence of bone morphogenetic proteins on Sost expression. Treatment with BMP-2, -4 or -6 was without effect on Sost in mature MLO-Y4 osteocytes but elicited a robust increase in Sost expression in immature MLO-A5 osteocytes. Oscillatory fluid flow applied to mature UMR 106.01 osteoblasts transiently decreased expression of sclerostin at both the mRNA and protein level. Overall, our results indicate that BMP treatment and in vitro mechanical loading demonstrate opposite effects upon sclerostin expression.

AB - The anabolic effect of dynamic mechanical loading on skeletal architecture has been repeatedly demonstrated, but the cellular and molecular events occurring between load and ultimate bone formation remain obscure. The discovery of sclerostin, an antagonist of Wnt/Lrp5 signaling, and the sclerosing bone dysplasias that result from its mutation suggest its pivotal role in modulating bone formation. We examined expression of Sost mRNA across a variety of clonal cell lines spanning the osteogenic phenotype from immature osteoblast to mature osteocyte. No sclerostin expression was detected in immature MC3T3-E1 osteoblasts and, surprisingly, mature MLO-Y4 osteocytes, whereas immature MLO-A5 osteocytic cells expressed very low levels of Sost. Highest expression was observed in mature UMR 106.01 osteoblasts. We examined the influence of bone morphogenetic proteins on Sost expression. Treatment with BMP-2, -4 or -6 was without effect on Sost in mature MLO-Y4 osteocytes but elicited a robust increase in Sost expression in immature MLO-A5 osteocytes. Oscillatory fluid flow applied to mature UMR 106.01 osteoblasts transiently decreased expression of sclerostin at both the mRNA and protein level. Overall, our results indicate that BMP treatment and in vitro mechanical loading demonstrate opposite effects upon sclerostin expression.

KW - BMP

KW - Fluid flow

KW - Osteoblast

KW - Osteocyte

KW - Shear stress

KW - Sost

UR - http://www.scopus.com/inward/record.url?scp=72949088669&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=72949088669&partnerID=8YFLogxK

U2 - 10.3233/BIR-2009-0550

DO - 10.3233/BIR-2009-0550

M3 - Article

C2 - 19940355

AN - SCOPUS:72949088669

VL - 46

SP - 389

EP - 399

JO - Biorheology

JF - Biorheology

SN - 0006-355X

IS - 5

ER -